UPDATE: JP Morgan Initiates Cerner at Overweight on Leadership, Outlook
JP Morgan initiated coverage on Cerner (NASDAQ: CERN) with an Overweighr rating and a $93 price target
JP Morgan commented, "In the large hospital market (>200 beds), Cerner has ~21% market share of clinical systems, just behind privately-held Epic. Cerner has been gaining share in recent years, improving from just 15% market share in 2005, while competitors have been losing ground. The top 3 clinical system vendors account for 65% of the market, yet we believe dissatisfaction with other large vendors should create opportunities for market share gains for Cerner."
Cerner closed at $80.45 on Wednesday.
Latest Ratings for CERN
|Nov 2014||Cowen & Company||Upgrades||Market Perform||Outperform|
|Oct 2014||Credit Suisse||Maintains||Neutral|
|Sep 2014||Topeka Capital||Maintains||Buy|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.